Dr. Rarick has worked as a consultant to the pharmaceutical industry since leaving the FDA in 2003 and is an expert in US regulatory interactions and reproductive health.  

Board-certified in Obstetrics and Gynecology (Georgetown University, Washington DC), she worked

at the US Food and Drug Administration from 1988 to 2003. Dr. Rarick first joined the FDA in the Center for Drug Evaluation and Research (CDER) as a clinical reviewer and then Division Director for the Division of Reproductive and Urologic Products. 

She subsequently held several upper management roles in CDER including executive positions in the Office of New Drugs and in the Office of the Center Director as leader of the Quality Assurance and Review Standards Program.  

Lisa founded and led the internal FDA educational effort called “New Reviewers Workshop” as well as made multiple presentations to industry groups and others on behalf of the FDA. Dr. Rarick spent her last year at FDA in the Office of Women’s Health in the Commissioner’s Office.